Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,308 | -4,282 | -4,530 | -2,011 | -1,094 |
| Depreciation Amortization | 2 | N/A | 1 | 1 | N/A |
| Other Working Capital | -735 | 1,938 | 730 | 396 | 118 |
| Other Operating Activity | 2,059 | 1,332 | 1,609 | 516 | 200 |
| Operating Cash Flow | $-5,982 | $-1,012 | $-2,190 | $-1,098 | $-776 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -120 | N/A | 0 | N/A | N/A |
| Investing Cash Flow | $-120 | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 56,512 | 56,512 | 2,061 | 751 | N/A |
| Other Financing Activity | -948 | -922 | 1,019 | 1,101 | 1,061 |
| Financing Cash Flow | $55,564 | $55,590 | $3,080 | $1,852 | $1,061 |
| Beginning Cash Position | 887 | 887 | 0 | N/A | N/A |
| End Cash Position | 50,349 | 55,465 | 880 | 754 | 285 |
| Net Cash Flow | $49,462 | $54,578 | $880 | $754 | $285 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,982 | -1,012 | -2,190 | -1,098 | -776 |
| Capital Expenditure | -120 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -6,102 | -1,012 | -2,190 | -1,098 | -776 |